Northwestern University enrols first subject in trial of drug for pericarditis
The trial is structured to enrol 110 subjects across nearly 20 clinical sites in Canada, Europe and the US.
Clinical Trials
Cullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trial
Sabin Vaccine Institute begins trial of vaccine candidate for Marburg virus disease
Hoth Therapeutics reports interim data from Phase IIa trial of HT-001 for pruritus
Accent Therapeutics starts dosing in trial of KIF18A inhibitor for solid tumours
DSMB recommends continuation of BioCardia’s cell therapy trial for heart failure
Corxel to begin trial of CX11 for obesity with FDA clearance
Neuren confirms Phase III trial goals for PMS drug NNZ-2591
